Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RHEUMATOID ARTHRITIS

Could IL-6 inhibition prevent exercise-induced fat loss in RA?

New research indicates that tocilizumab limits the beneficial effects of exercise on abdominal fat loss. What does this mean for patients with chronic disease who are being treated with tocilizumab or other inhibitors of IL-6 signalling?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Exercise and IL-6 inhibition in rheumatoid arthritis.

References

  1. Wedell-Neergaard, A.-S. et al. Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized controlled trial. Cell Metab. https://doi.org/10.1016/j.cmet.2018.12.007 (2018).

    Article  PubMed  Google Scholar 

  2. Calabrese, L. H. & Rose-John, S. IL-6 biology: implications for clinical targeting in rheumatic disease. Nat. Rev. Rheumatol. 10, 720–727 (2014).

    Article  CAS  Google Scholar 

  3. Pedersen, B. K. & Febbraio, M. A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379–1406 (2008).

    Article  CAS  Google Scholar 

  4. Muñoz-Cánoves, P. et al. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 280, 4131–4148 (2013).

    Article  Google Scholar 

  5. Nurmohamed, M. T., Heslinga, M. & Kitas, G. D. Cardiovascular comorbidity in rheumatic diseases. Nat. Rev. Rheumatol. 11, 693–704 (2015).

    Article  CAS  Google Scholar 

  6. Metsios, G. S. & Lemmey, A. Exercise as medicine in rheumatoid arthritis: effects on function, body composition, and cardiovascular disease risk. J. Clin. Ex. Physiol. 4, 14–22 (2015).

    Google Scholar 

  7. Summers, G. D. et al. Rheumatoid cachexia and cardiovascular disease. Nat. Rev. Rheumatol. 6, 445–451 (2010).

    Article  Google Scholar 

  8. George, M. D. & Baker, J. F. The obesity epidemic and consequences for rheumatoid arthritis care. Curr. Rheumatol. Rep. 18, 6 (2016).

    Article  Google Scholar 

  9. Pers, Y.-M. et al. Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient. J. Rheumatol. 42, 580–584 (2015).

    Article  CAS  Google Scholar 

  10. Tournadre, A. et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J. Cachexia Sarcopenia Muscle 8, 639–646 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George D. Kitas.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stavropoulos-Kalinoglou, A., Kitas, G.D. Could IL-6 inhibition prevent exercise-induced fat loss in RA?. Nat Rev Rheumatol 15, 192–194 (2019). https://doi.org/10.1038/s41584-019-0189-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-019-0189-7

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing